Out-Licence Agreement Sample Contracts

Flexion therapeutics – Licence Agreement (January 29th, 2014)
Flexion therapeutics – Licence Agreement (January 29th, 2014)
Flexion therapeutics – Licence Agreement (January 8th, 2014)
Flexion therapeutics – Licence Agreement (January 8th, 2014)
Navidea Biopharmaceuticals, Inc. – Contract (April 11th, 2012)

Confidential Treatment - Asterisked material has been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment.

Navidea Biopharmaceuticals, Inc. – OUT-LICENCE AGREEMENT by and Between ASTRAZENECA AB and NEOPROBE CORPORATION DATE: 9 DECEMBER 2011 (December 15th, 2011)

to make, have made, import, use, including to research, develop, register, modify, enhance, improve, Manufacture, have Manufactured, hold/keep, have used, export, transport, distribute (but, for the avoidance of doubt not sell, distribute, market or promote) the Compound and the Licensed Product in the Field for use solely as a biomarker for the purpose of development of pharmaceutical products; provided, however, that prior to any such use by AstraZeneca of the Compound or the Licensed Product AstraZeneca shall notify the JSC in writing about such planned use describing the planned studies or other use in reasonable detail to allow the JSC to assess whether the safety profile of the Licensed Product would be negatively impacted by the intended use by AstraZeneca. The JSC shall be allowed a reasonable period of time but no more than three (3) weeks from such AstraZeneca's notice to make such assessment and may within such period raise by giving notice in writing to AstraZeneca any conc